Europe · 12 mins ago

TDs call on pharma company to work with HSE to give access to life-changing drug Skyclarys

The HSE has refused to fund the drug, which costs €288,000 per patient per year.

Do you trust TheJournal.ie?

Sign in to rate

Discussion

?

No comments yet — be the first to start the discussion!